Aiming for novel treatments for type 2 diabetes and its kidney complication

The work of Sanna Lehtonen's laboratory focuses on characterizing the mechanisms involved in the development of insulin resistance and type 2 diabetes. Specifically, we are interested in the pathophysiology associated with the development of albuminuria in diabetic kidney disease, the kidney complication of diabetes. We aim to identify novel drug targets and drugs that can be used to develop treatments for these diseases.